Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

March 11, 2016

New York/New Delhi—Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a "patent opposition" in India to block US pharmaceutical company Pfizer from patenting a pneumococcal conjugate vaccine, and ensure affordable access to this critical vaccine (PCV13). This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organization and, if successful, will make affordable versions of this lifesaving vaccine available to developing countries and humanitarian organizations.

March 10, 2016

Judit Rius Sanjuan, Access Campaign manager & legal policy advisor at Doctors Without Borders/Médecins Sans Frontières (MSF), made the following statement after KaloBios Pharmaceuticals obtained bankruptcy court permission to keep pursing a drug that could receive a US Federal Drug Administration Priority Review Voucher (PRV).

March 10, 2016

PARIS/NEW YORK—Doctors Without Borders/Médecins Sans Frontières (MSF) recently constructed a new site for migrants and refugees who were living in the mud and cold at the Basroch camp in Grande-Synthe, near Dunkirk in northern France. The new camp has the capacity to house 2,500 people, but it is already being threatened with closure by French authorities.

March 09, 2016

New York— A Senate committee voted today to add Zika to the list of diseases eligible for the US Federal Drug Administration (FDA) Priority Review Voucher (PRV) program for neglected diseases, but did not fix major loopholes that make the PRV program for neglected diseases ripe for abuse by pharmaceutical companies.

March 08, 2016
March 04, 2016

"A resolution is a welcome step but only if it shows an unwavering commitment to ensuring that health workers, facilities, and patients never come under attack. Several permanent members of the United Nations Security Council have over recent months been engaged in, or have supported, military activities resulting in destruction of health facilities. Therefore, any new resolution will require states in the security council, notably the permanent members, to lead by example.

March 04, 2016

JUBA, SOUTH SUDAN/BRUSSELS— Doctors Without Borders/Médecins Sans Frontières (MSF) strongly condemns the looting of its medical center in Pibor, in South Sudan’s Jonglei State, during and after heavy fighting from February 23 to 25 that also destroyed large sections of the town, leaving thousands of people in need of aid.

March 02, 2016

Thousands of displaced people need protection and aid after widespread destruction and killings.

March 01, 2016

PORT MORESBY, PAPUA NEW GUINEA/BERLIN—A new report from Doctors Without Borders/Médecins Sans Frontières (MSF) examines the shocking levels of family and sexual violence in Papua New Guinea, which are among the highest in the world outside of conflict zones.

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

Pages